You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
The Drug Enforcement Administration published its proposed rescheduling of cannabis today. There is a comment period that ends on July 22nd. The biggest outcome of cannabis being rescheduled from...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
According to a recently filed S-1/A, Bright Green Corporation (NASDAQ: BGXX) is one of the few companies who have received conditional approval with the DEA to produce federally legal cannabis...
Last week, GW Pharma (NASDAQ: GWPH) scored a milestone victory, as the thirteen-member panel at the Peripheral and Central Nervous System Drugs Advisory Committee, which met on April 19th to consider...
DÉJÀ VU? IS THE DEA UNLAWFULLY ATTEMPTING TO OUTLAW ALL CANNABINOIDS…AGAIN? Guest post by Robert Hoban, Managing Partner at Hoban Law Group The feeling is that this is an...
Leading National Trade Association for Industrial Hemp Products Issues Response to Joint USDA & DEA Statement of Principles on Industrial Hemp WASHINGTON, Aug. 17, 2016 /PRNewswire-USNewswire/ — The Hemp...
Confirming reports from unnamed sources published last night, Chuck Rosenberg, the Acting Administrator of the Drug Enforcement Agency (DEA), issued a harshly worded 186-page rejection of a request by former Governors...
The long awaited DEA decision on rescheduling cannabis has apparently been made, and, similar to prior considerations, there will be no change, according to the NY Times, which cited...
